SEARCH

SEARCH BY CITATION

References

  • Abe K., Pan L. H., Watanabe M., Kato T. & Itoyama Y. (1995) Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199, 152154.DOI: 10.1016/0304-3940(95)12039-7
  • Batteur-Parmentier S., Margaill I. & Plotkine M. (2000) Modulation by nitric oxide of cerebral neutrophil accumulation after transient focal ischemia in rats. J. Cereb. Blood Flow Metab. 20, 812819.
  • Beckman J. S. & Koppenol W. H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424C1437.
  • Benveniste H., Drejer J., Schousboe A. & Diemer N. H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 13691374.
  • Biegon A., Brewster M., Degani H., Pop E., Somjen D. & Kaye A. M. (1996) A permanently charged tamoxifen derivative displays anticancer activity and improved tissue selectivity in rodents. Cancer Res. 56, 43284331.
  • Bolanos J. P. & Almeida A. (1999) Roles of nitric oxide in brain hypoxia−ischemia. Biochim. Biophys. Acta 1411, 415436.
  • Bredt D. S. & Snyder S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl Acad. Sci. USA 86, 90309033.
  • Butta A., MacLennan K. & Flanders K. C. et al. (1992) Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res. 52, 42614264.
  • Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623634.
  • Choi D. W. (1995) Calcium: still center-stage in hypoxic−ischemic neuronal death. Trends Neurosci. 18, 5860.DOI: 10.1016/0166-2236(95)93870-4
  • Coeroli L., Renolleau S., Arnaud S., Plotkine D., Cachin N., Plotkine M., Ben-Ari Y. & Charriaut-Marlangue C. (1998) Nitric oxide production and perivascular tyrosine nitration following focal ischemia in neonatal rat. J. Neurochem. 70, 25162525.
  • Eliasson M. J. L., Huang Z., Ferrante R. J., Sasamata M., Molliver M. E., Snyder S. H. & Moskowitz M. A. (1999) Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 19, 59105918.
  • Fukuyama N., Takizawa S., Ishida H., Hoshiai K., Shinohara Y. & Nakazawa H. (1998) Peroxynitrite formation in focal cerebral ischemia−reperfusion in rats occurs predominantly in the peri-infarct region. J. Cereb. Blood Flow Metab. 18, 123129.
  • Furfine E. S., Harmon M. F., Paith J. E. & Garvey E. P. (1993) Selective inhibition of constitutive nitric oxide synthase by lNG-nitroarginine. Biochemistry 32, 85128517.
  • Green P. S. & Simpkins J. W. (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18, 347358.DOI: 10.1016/s0736-5748(00)00017-4
  • Hagberg H., Lehmann A., Sandberg M., Nystrom B., Jacobson I. & Hamberger A. (1985) Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J. Cereb. Blood Flow Metab. 5, 413419.
  • Hara H., Huang P. L., Panahian N., Fishman M. C. & Moskowitz M. A. (1996) Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric-oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab. 16, 605611.
  • Hayashi T., Ishikawa T., Yamada K., Kuzuya M., Naito M., Hidaka H. & Iguchi A. (1994) Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca2+-calmodulin dependent mechanism. Biochem. Biophys. Res. Commun. 203, 10131019.DOI: 10.1006/bbrc.1994.2283
  • Haynes M. P., Sinha D., Russell K. S., Collinge M., Fulton D., Morales-Ruiz M., Sessa W. C. & J. R. Bender. (2000) Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 87, 677682.
  • Hirabayashi H., Takizawa S., Fukuyama N., Nakazawa H. & Shinohara Y. (2000) Nitrotyrosine generation via inducible nitric oxide synthase in vascular wall in focal ischemia−reperfusion. Brain Res. 852, 319325.DOI: 10.1016/s0006-8993(99)02117-4
  • Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C. & Moskowitz M. A. (1994) Effects of cerebral ischemia in mice deficient neuronal nitric-oxide synthase. Science 265, 18831885.
  • Iadecola C., Zhang F., Casey R., Clark H. B. & Ross M. E. (1996) Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 27, 13731380.
  • Iadecola C., Zhang F., Casey R., Nagayama M. & Ross M. E. (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17, 91579164.
  • Jordan V. C. (1993) Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br. J. Pharmacol. 110, 507517.
  • Kimelberg H. K., Feustel P. J., Jin Y., Paquette J., Boulos A., Keller R. W. Jr & Tranmer B. I. (2000) Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion. Neuroreport 11, 26752679.
  • Kirk J. & Kirk K. (1994) Inhibition of volume-activated I- and taurine efflux from HeLa cells by P-glycoprotein blockers correlates with calmodulin inhibition. J. Biol. Chem. 269, 2938929394.
  • Kuroda S., Nakai A., Kristian T. & Siesjo B. K. (1997) The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats. Anti-ischemic effect and therapeutic window. Stroke 28, 25392544.
  • Lam H. Y. (1984) Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem. Biophys. Res. Commun. 118, 2732.
  • Lo E. H., Hara H., Rogovska J., Trocha M., Pierce A. R., Huang P. L., Fishman M. C., Wolf G. L. & Moskowitz M. A. (1996) Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric-oxide synthase gene-expression. Stroke 27, 13811385.
  • Longa E. Z., Weinstein P. R., Carlson S. & Cummins R. (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 8491.
  • Lopes M. C., Vale M. G. & Carvalho A. P. (1990) Ca2+-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Res. 50, 27532758.
  • Love R. R., Wiebe D. A., Newcomb P. A., Cameron L., Leventhal H., Jordan V. C., Feyzi J. & DeMets D. L. (1991) Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann. Intern. Med. 115, 860864.
  • MacGregor J. I. & Jordan V. C. (1998) Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50, 151196.
  • Massom L., Lee H. & Jarrett H. W. (1990) Trifluoperazine binding to porcine brain calmodulin and skeletal muscle troponin C. Biochemistry 29, 671681.
  • Mesenge C., Charriaut-Marlangue C., Verrecchia C., Allix M., Boulu R. R. & Plotkine M. (1998) Reduction of tyrosine nitration after N(omega)-nitro-l-arginine-methylester treatment of mice with traumatic brain injury. Eur. J. Pharmacol. 353, 5357.DOI: 10.1016/s0014-2999(98)00432-4
  • Mongin A. A., Cai Z. & Kimelberg H. K. (1999) Volume-dependent taurine release from cultured astrocytes requires permissive [Ca2+]i and calmodulin. Am. J. Physiol. 277, C823C832.
  • Otani H., Engelman R. M., Rousou J. A., Breyer R. H., Clement R., Prasad R., Klar J. & Das D. K. (1989) Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization. J. Thorac. Cardiovasc. Surg. 97, 267274.
  • Phillis J. W., Song D. & O'Regan M. H. (1998) Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex. Brain Res. 780, 352355.DOI: 10.1016/s0006-8993(97)01352-8
  • Renodon A., Boucher J. L., Sari M. A., Delaforge M., Ouazzani J. & Mansuy D. (1997) Strong inhibition of neuronal nitric oxide synthase by the calmodulin antagonist and anti-estrogen drug tamoxifen. Biochem. Pharmacol. 54, 11091114.DOI: 10.1016/s0006-2952(97)00316-x
  • Rutledge E. M., Aschner M. & Kimelberg H. K. (1998) Pharmacological characterization of swelling-induced d-[3H]aspartate release from primary astrocyte cultures. Am. J. Physiol. 274, C1511C1520.
  • Sargent C. A., Sleph P. G., Dzwonczyk S., Smith M. A. & Grover G. J. (1992) Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat hearts. J. Cardiovasc. Pharmacol. 20, 251260.
  • Sato T., Morishima Y., Sugimura M., Uchida T. & Shirasaki Y. (1999) DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia. Eur. J. Pharmacol. 370, 117123.DOI: 10.1016/s0014-2999(99)00133-8
  • Sawada M., Alkayed N. J., Goto S., Crain B. J., Traystman R. J., Shaivitz A., Nelson R. J. & Hurn P. D. (2000) Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J. Cereb. Blood Flow Metab. 20, 112118.
  • Seki Y., Feustel P. J., Keller R. W. Jr, Tranmer B. I. & Kimelberg H. K. (1999) Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 30, 433440.
  • Shaw G., Osborn M. & Weber K. (1981) An immunofluorescence microscopical study of the neurofilament triplet proteins, vimentin and glial fibrillary acidic protein within the adult rat brain. Eur. J. Cell Biol. 26, 6882.
  • Siesjo B. K. & Bengtsson F. (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9, 127140.
  • Simoncini T. & Genazzani A. R. (2000) Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J. Clin. Endocrinol. Metab. 85, 29662969.
  • Simpkins J. W., Rajakumar G., Zhang Y. Q., Simpkins C. E., Greenwald D., Yu C. J., Bodor N. & Day A. L. (1997) Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87, 724730.
  • Smith M. A., Richey H. P. L., Sayre L. M., Beckman J. S. & Perry G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 26532657.
  • Strong M. J., Sopper M. M., Crow J. P., Strong W. L. & Beckman J. S. (1998) Nitration of the low molecular weight neurofilament is equivalent in sporadic amyotrophic lateral sclerosis and control cervical spinal cord. Biochem. Biophys. Res. Commun. 248, 157164.DOI: 10.1006/bbrc.1998.8930
  • Toung T. J., Traystman R. J. & Hurn P. D. (1998) Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29, 16661670.
  • Tymianski M. & Tator C. H. (1996) Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38, 11761195.
  • Wang Q., Santizo R., Baughman V. L., Pelligrino D. A. & Iadecola C. (1999) Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 30, 630637.
  • Wiseman H., Quinn P. & Halliwell B. (1993) Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions? FEBS Lett. 330, 5356.
  • Xu J., He L., Ahmed S. H., Chen S. W., Goldberg M. P., Beckman J. S. & Hsu C. Y. (2000) Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke 31, 17441751.
  • Yang S. H., Shi J., Day A. L. & Simpkins J. W. (2000) Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31, 745749,.
  • Yoshida T., Limmroth V., Irikura K. & Moskowitz M. A. (1994) The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14, 924929.
  • Zhang Z. G., Chopp M., Gautam S., Zaloga C., Zhang R. L., Schmidt H. H., Pollock J. S. & Forstermann U. (1994) Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res. 654, 8595.